4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-003362
Chief Executive Officer gave up 5,219 shares (to pay taxes)
- Chief Executive Officer acquired 19,768 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quart Barry D Chief Executive Officer | 2022-01-13 | Option exercise | +3,646 | 105,732 | D | ||
| Quart Barry D Chief Executive Officer | 2022-01-13 | Option exercise | +16,122 | 121,854 | D | ||
| Quart Barry D Chief Executive Officer | 2022-01-13 | Shares withheld for taxes | −5,219 | $8.30 | $43,318 | 116,635 | D |
| Derivatives | |||||||
| Quart Barry D Chief Executive Officer | 2022-01-13 | Option exercise · Restricted Stock Units | −3,646 | 40,104 | D | ||
| Quart Barry D Chief Executive Officer | 2022-01-13 | Option exercise · Restricted Stock Units | −16,122 | 179,295 | D | ||
Loading xslF345X03/doc4.xml…